Lindestam Arlehamn Cecilia S, McKinney Denise M, Carpenter Chelsea, Paul Sinu, Rozot Virginie, Makgotlho Edward, Gregg Yolande, van Rooyen Michele, Ernst Joel D, Hatherill Mark, Hanekom Willem A, Peters Bjoern, Scriba Thomas J, Sette Alessandro
La Jolla Institute for Allergy and Immunology, Department of Vaccine Discovery, La Jolla, California, United States of America.
South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
PLoS Pathog. 2016 Jul 13;12(7):e1005760. doi: 10.1371/journal.ppat.1005760. eCollection 2016 Jul.
We performed a quantitative analysis of the HLA restriction, antigen and epitope specificity of human pathogen specific responses in healthy individuals infected with M. tuberculosis (Mtb), in a South African cohort as a test case. The results estimate the breadth of T cell responses for the first time in the context of an infection and human population setting. We determined the epitope repertoire of eleven representative Mtb antigens and a large panel of previously defined Mtb epitopes. We estimated that our analytic methods detected 50-75% of the total response in a cohort of 63 individuals. As expected, responses were highly heterogeneous, with responses to a total of 125 epitopes detected. The 66 top epitopes provided 80% coverage of the responses identified in our study. Using a panel of 48 HLA class II-transfected antigen-presenting cells, we determined HLA class II restrictions for 278 epitope/donor recognition events (36% of the total). The majority of epitopes were restricted by multiple HLA alleles, and 380 different epitope/HLA combinations comprised less than 30% of the estimated Mtb-specific response. Our results underline the complexity of human T cell responses at a population level. Efforts to capture and characterize this broad and highly HLA promiscuous Mtb-specific T cell epitope repertoire will require significant peptide multiplexing efforts. We show that a comprehensive "megapool" of Mtb peptides captured a large fraction of the Mtb-specific T cells and can be used to characterize this response.
我们在一个南非队列中,以感染结核分枝杆菌(Mtb)的健康个体为测试对象,对人类病原体特异性反应的HLA限制、抗原和表位特异性进行了定量分析。研究结果首次在感染和人群背景下估计了T细胞反应的广度。我们确定了11种代表性Mtb抗原的表位库以及大量先前定义的Mtb表位。我们估计,在一个63人的队列中,我们的分析方法检测到了总反应的50%-75%。正如预期的那样,反应高度异质性,共检测到对125个表位的反应。66个顶级表位覆盖了我们研究中确定的80%的反应。使用一组48个HLA II类转染抗原呈递细胞,我们确定了278个表位/供体识别事件的HLA II类限制(占总数的36%)。大多数表位受多个HLA等位基因限制,380种不同的表位/HLA组合占估计的Mtb特异性反应的不到30%。我们的结果强调了人群水平上人类T细胞反应的复杂性。要捕获和表征这种广泛且高度HLA混杂的Mtb特异性T细胞表位库,需要大量的肽多重分析工作。我们表明,一个全面的Mtb肽“超级库”捕获了大部分Mtb特异性T细胞,可用于表征这种反应。